ATE282406T1 - Arzneimittel und verfahren zur behandlung von intrazellulären infektionen - Google Patents

Arzneimittel und verfahren zur behandlung von intrazellulären infektionen

Info

Publication number
ATE282406T1
ATE282406T1 AT99943687T AT99943687T ATE282406T1 AT E282406 T1 ATE282406 T1 AT E282406T1 AT 99943687 T AT99943687 T AT 99943687T AT 99943687 T AT99943687 T AT 99943687T AT E282406 T1 ATE282406 T1 AT E282406T1
Authority
AT
Austria
Prior art keywords
treatment
methods
medicinal products
microspheres
intracellular infections
Prior art date
Application number
AT99943687T
Other languages
English (en)
Inventor
William W Barrow
Esther L Barrow
Debra C Quenelle
Gary A Winchester
Jay K Staas
Original Assignee
Southern Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Res Inst filed Critical Southern Res Inst
Application granted granted Critical
Publication of ATE282406T1 publication Critical patent/ATE282406T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT99943687T 1998-08-18 1999-08-12 Arzneimittel und verfahren zur behandlung von intrazellulären infektionen ATE282406T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/135,708 US6264991B1 (en) 1998-08-18 1998-08-18 Compositions and methods for treating intracellular infections
PCT/US1999/018308 WO2000010533A2 (en) 1998-08-18 1999-08-12 Compositions and methods for treating intracellular infections

Publications (1)

Publication Number Publication Date
ATE282406T1 true ATE282406T1 (de) 2004-12-15

Family

ID=22469290

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99943687T ATE282406T1 (de) 1998-08-18 1999-08-12 Arzneimittel und verfahren zur behandlung von intrazellulären infektionen

Country Status (8)

Country Link
US (1) US6264991B1 (de)
EP (1) EP1105101B1 (de)
AT (1) ATE282406T1 (de)
AU (1) AU5673399A (de)
CA (1) CA2340898C (de)
DE (1) DE69922017T2 (de)
ES (1) ES2234291T3 (de)
WO (1) WO2000010533A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775459B2 (en) * 1999-10-04 2004-08-05 Lawrence R. Bernstein Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, DNA viruses and retroviruses
NZ521368A (en) * 2000-03-28 2004-05-28 Biochemie Ges M Granulated particles of an active compound, with a film-forming coating resulting in the masked taste of said active compound
AU778389C (en) * 2000-08-09 2006-12-14 Panacea Biotec Limited Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation
DE10139965B4 (de) * 2001-08-14 2005-12-29 Biotest Ag Gammasterilisierbares Kulturmedium zum Nachweis von Hefen und Pilzen
US20030236265A1 (en) * 2002-05-23 2003-12-25 Sayada Chalom B. Methods of treating bacterial infections and diseases associated therewith
US20090149453A1 (en) * 2002-05-23 2009-06-11 Activbiotics Pharma Llc Methods and compositions for treating bacterial infections and diseases associated therewith
US20040077533A1 (en) * 2002-05-23 2004-04-22 Sayada Chalom B. Methods and compositions for treating bacterial infections and diseases associated therewith
DE60326742D1 (de) * 2002-10-03 2009-04-30 Vertex Pharma Piperazin und piperadin-derivate für die behandlung von neurologischen krankheiten
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
US20050084455A1 (en) * 2003-10-16 2005-04-21 Council Of Scientific & Industrial Research Inhalable biodegradable microparticles for target-specific drug delivery in tuberculosis and a process thereof
RU2318513C1 (ru) * 2007-04-10 2008-03-10 Автономная некоммерческая организация "Институт молекулярной диагностики" (АНО "ИнМоДи") Лекарственное средство на основе d-циклосерина, препарат пролонгированного действия, содержащий наночастицы, способ его получения
RU2327459C1 (ru) * 2007-06-26 2008-06-27 Евгений Сергеевич Северин Лекарственное средство противомикробного действия, способ получения лекарственного препарата направленного действия, содержащего наночастицы
WO2009042114A2 (en) 2007-09-21 2009-04-02 The Johns Hopkins University Phenazine derivatives and uses thereof
KR20100119539A (ko) * 2007-12-10 2010-11-09 유란드, 인코포레이티드 다이펜하이드라민을 포함하는 경구 분해성 정제
US20110269720A1 (en) * 2010-04-28 2011-11-03 Medtronic, Inc. Minocycline and rifampin microparticles
US9248176B2 (en) 2010-10-07 2016-02-02 The Texas A&M University System Controlled release vaccines and methods for treating Brucella diseases and disorders
RU2470071C2 (ru) * 2010-11-25 2012-12-20 Федеральное государственное учреждение "Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии"Министерства здравоохранения и социального развития Российской Федерации (ФГУ "СПб НИИФ" Минздравсоцразвития России) ПИТАТЕЛЬНАЯ СРЕДА ДЛЯ УСКОРЕННОГО ОПРЕДЕЛЕНИЯ ЛЕКАРСТВЕННОЙ ЧУВСТВИТЕЛЬНОСТИ M. tuberculosis К ОСНОВНЫМ ПРОТИВОТУБЕРКУЛЕЗНЫМ ПРЕПАРАТАМ
CN102228439B (zh) * 2011-06-21 2013-01-02 中国人民解放军第三0九医院 可注射利福霉素类抗生素凝胶微球及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783484A (en) 1984-10-05 1988-11-08 University Of Rochester Particulate composition and use thereof as antimicrobial agent
EP0257915B1 (de) 1986-08-11 1993-03-10 Innovata Biomed Limited Mikrokapseln enthaltende pharmazeutische Zusammensetzungen
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
JP2670680B2 (ja) 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
JP2582186B2 (ja) 1989-05-04 1997-02-19 サウザン リサーチ インスティチュート カプセル封じ法及びその製品
WO1991009616A1 (en) 1989-12-22 1991-07-11 Yale University Quinolone antibiotics encapsulated in lipid vesicles
EP0752245B1 (de) 1995-07-05 2002-05-22 European Community Biokompatibele und biodegradierbare Nanokapseln zur Absorption und Verabreichung von proteinischen Arzneimitteln
US5980948A (en) * 1996-08-16 1999-11-09 Osteotech, Inc. Polyetherester copolymers as drug delivery matrices
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6120751A (en) * 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
SE9801288D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
US6548302B1 (en) * 1998-06-18 2003-04-15 Johns Hopkins University School Of Medicine Polymers for delivery of nucleic acids

Also Published As

Publication number Publication date
US6264991B1 (en) 2001-07-24
DE69922017T2 (de) 2005-11-24
ES2234291T3 (es) 2005-06-16
WO2000010533A3 (en) 2000-06-08
WO2000010533A2 (en) 2000-03-02
DE69922017D1 (de) 2004-12-23
EP1105101A2 (de) 2001-06-13
AU5673399A (en) 2000-03-14
HK1038310A1 (en) 2002-03-15
EP1105101B1 (de) 2004-11-17
WO2000010533A9 (en) 2000-08-03
CA2340898C (en) 2009-06-16
CA2340898A1 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
ATE282406T1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
ES2569949T3 (es) Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
ATE228832T1 (de) System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
RU95109905A (ru) Композиции в жидком, полутвердом, твердом, гелеобразном или пастообразном виде и способ лечения заболеваний полости рта
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
DE60138547D1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
DE69840495D1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
HUP0102899A2 (hu) Eljárás gyulladásgátló, különösen fertőtlenítő hatású és/vagy sebgyógyulást elősegítő szerek alsó légutakba történő beadására szolgáló készítmények előállítására
ATE284179T1 (de) Implantierbare vorrichtung zur kontrollierten abgabe von arzneimitteln unmittelbar an einen inneren teil des körpers
ATE209908T1 (de) RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
ATE146677T1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
DE69519685D1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
GEP20032941B (en) Gastroprotected Omerprazole Microgranules, Method for Obtaining Same and Pharmaceutical Preparations
ATE249819T1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
ATE356637T1 (de) Supramolekulare komplexe enthaltende arzneimittel
ATE265851T1 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
DK0684812T3 (da) Kondenseret-fase mikropartikel-præparat og fremgangsmåde
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
DE69733169D1 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
ATE228843T1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1105101

Country of ref document: EP

REN Ceased due to non-payment of the annual fee